362623-99-2

Upstream product

• 547-63-7 Methyl isobutyrate 
• 100-39-0 benzyl bromide 
• 94426-72-9 2-(2-(benzyloxy)ethyl)oxirane 
• 362623-95-8 (3S,5S)-5,7-Bis-benzyloxy-3-triisopropylsilanyloxy-heptan-1-ol 
• 362623-96-9 (3R,5S)-5,7-Bis-benzyloxy-3-triisopropylsilanyloxy-heptanal 
• 362623-94-7 ((1R,3S)-3,5-Bis-benzyloxy-1-vinyl-pentyloxy)-triisopropyl-silane 
• 362623-88-9 2-((R)-5,7-Bis-benzyloxy-hept-2-ynyloxy)-tetrahydro-pyran 
• 362623-92-5 (2R,3S)-2-((S)-2,4-Bis-benzyloxy-butyl)-3-iodomethyl-oxirane 
• 362623-91-4 ((2R,3R)-3-((S)-2,4-bis(benzyloxy)butyl)oxiran-2-yl)methanol 
• 362623-87-8 (R)-1-Benzyloxy-7-(tetrahydro-pyran-2-yloxy)-hept-5-yn-3-ol 
• 362623-89-0 (R)-5,7-Bis-benzyloxy-hept-2-yn-1-ol 
• 362623-90-3 (E)-(R)-5,7-Bis-benzyloxy-hept-2-en-1-ol 
• 362623-93-6 (3R,5S)-5,7-Bis-benzyloxy-hept-1-en-3-ol 
• 85960-55-0 (S)-(2-phenylmethoxyethyl)oxirane 

Downstream Products

• 362624-00-8 2-[(4S,6R)-6-((S)-2,4-Bis-benzyloxy-butyl)-2,2-dimethyl-[1,3]dioxan-4-yl]-2-methyl-propionic acid methyl ester 
• 362624-01-9 {3-[(4S,6R)-6-((S)-2,4-Bis-benzyloxy-butyl)-2,2-dimethyl-[1,3]dioxan-4-yl]-3-methyl-2-oxo-butyl}-phosphonic acid dimethyl ester 
• 362624-15-5 3-[(4S,6R)-6-((S)-2,4-Bis-benzyloxy-butyl)-2,2-dimethyl-[1,3]dioxan-4-yl]-1-((7R,9R)-9-methoxymethoxymethyl-1,4,8-trioxa-spiro[4.5]dec-7-yl)-3-methyl-butan-2-one 
• 362624-14-4 (E)-2-[(4S,6R)-6-((S)-2,4-Bis-benzyloxy-butyl)-2,2-dimethyl-[1,3]dioxan-4-yl]-6-{2-[(R)-2-(tert-butyl-dimethyl-silanyloxy)-3-methoxymethoxy-propyl]-[1,3]dioxolan-2-yl}-2-methyl-hex-4-en-3-one 

Relevant academic research and scientific papers

An approach towards the C1-C16 fragment of antineoplastic macrolide bryostatins by kinetic resolution of a racemic terminal epoxide using Jacobsen's catalyst

A stereo- and enantioselective approach towards the C1-C16 fragment of bryostatins is reported using Jacobsen's catalyst for kinetic resolution of a terminal epoxide, a Horner-Wadsworth-Emmons coupling reaction and a 1,4-Michael type cyclization as key steps.